Lataa...
用于治疗非小细胞肺癌的阿法替尼脂质体的制备与包封率的测定
BACKGROUND AND OBJECTIVE: Afatinib, a second-generation irreversible epidermal growth factor inhibitor receptor for the development of non-small cell lung cancer and secondary drug resistance, has low bioavailability and adverse reactions due to current oral administration. The aim of this study was...
Tallennettuna:
| Julkaisussa: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
中国肺癌杂志编辑部
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136998/ https://ncbi.nlm.nih.gov/pubmed/30201064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2018.09.02 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|